The Valley Desk

NCT06395103 · Interventional trial

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, Ewing Sarcoma, Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov